For a listing of the top 10 pharmaceutical/biotechnology companies ranked by DTC media breakdown in 2014, please click on the link below: Top 10 Companies Media Breakdown MAN0615

For a listing of the top 20 pharma/biotech companies ranked by DTC spending in 2014, please click on the link below: Top 20 Companies DTC MAN0615

For a listing of the top 20 prescription medicines ranked by DTC expenditure in 2014, please click on the link below: Top 20 Brands DTC MAN0615

For a listing of media type based on DTC expenditure in 2014, please click on the link below: Media Type DTC MAN0615

For a listing of the total DTC expenditure for prescription medicines in 2012, 2013 and 2014, please click on the link below: Total DTC Spend 2012-2014 MAN0615

For a listing of the top 100 biotechnology companies ranked by 2014 R&D, please click on the link below: R&D Top 100 Layout MAN0615

For a listing of the top 100 biotechnology companies ranked by 2014 revenue, please click on the link below: Revenue Top 100 Layout MAN0615

The U.S. biotechnology arena is undergoing a record-breaking M&A cycle for the industry. After generating M&A activity valued at $235 billion during 2014, the U.S. biotech sector produced more than $100 billion in deals during first-quarter 2015.

By John Kamp • Executive Director of the Coalition for Healthcare Communication So, you already know that the 300+ page bill which includes a broad array of amendments related to the National Institute of Health (NIH) and the Food and Drug Administration (FDA) passed out of the House Commerce Committee on May 21 by an […]

Changes at the top at Giant Steven Gold has been selected as CEO and Jeffrey Nemy has joined the company as chief financial officer. Gold, who is one of Giant’s co-founders, has served as an agency principal since its start 13 years ago. In the CEO role, Gold provides leadership and oversight to the company’s […]